OverviewSuggest Edit

Rodeo Therapeutics is a preclinical-stage biopharmaceutical company. It is focused on novel enzyme target and biological pathway that play a critical role in tissue repair and regeneration. Rodeo’s initial goal is to develop novel small molecules therapies for the treatment of inflammatory bowel disease and the promotion of blood cell reconstitution following bone marrow transplant.

TypePrivate
HQSeattle, US
Websiterodeotherapeutics.com

Locations

Rodeo Therapeutics is headquartered in
Seattle, United States

Location Map

Key People/Management at Rodeo Therapeutics

Sanford Markowitz

Sanford Markowitz

Founder
Joseph Ready

Joseph Ready

Founder
Stanton Gerson

Stanton Gerson

Founder
Show more

Rodeo Therapeutics Office Locations

Rodeo Therapeutics has an office in Seattle
Seattle, US (HQ)
1616 Eastlake Ave E #200
Show all (1)
Report incorrect company information

Rodeo Therapeutics Financials and Metrics

Summary Metrics

Rodeo Therapeutics total Funding

$5.9 m

Rodeo Therapeutics latest funding size

$5.90 m

Time since last funding

2 years ago

Rodeo Therapeutics investors

Rodeo Therapeutics's latest funding round in July 2017 was reported to be $5.9 m. In total, Rodeo Therapeutics has raised $5.9 m
Show all financial metrics
Report incorrect company information

Rodeo Therapeutics Frequently Asked Questions

  • Who are Rodeo Therapeutics key executives?

    Rodeo Therapeutics's key executives are Sanford Markowitz, Joseph Ready and Stanton Gerson.

  • Who are Rodeo Therapeutics competitors?

    Competitors of Rodeo Therapeutics include Gilead Sciences, GlaxoSmithKline and Bristol-Myers Squibb.

  • Where is Rodeo Therapeutics headquarters?

    Rodeo Therapeutics headquarters is located at 1616 Eastlake Ave E #200, Seattle.

  • Where are Rodeo Therapeutics offices?

    Rodeo Therapeutics has an office in Seattle.

  • How many offices does Rodeo Therapeutics have?

    Rodeo Therapeutics has 1 office.